Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 23, 2021-- Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies,...
